Evidence map›Paper›PMID 36985425›Full record

ArticleMolecules (Basel, Switzerland)2023

The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer.

Ahmed A Ahmed, William Greenhalf, Daniel H Palmer, Nicole Williams, Jenny Worthington, Tariq Arshad, Shozeb Haider, Effrosyni Alexandrou, Dilek Guneri, Zoe A E Waller and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Naphthalene diimides for G4s.Nature chemistry · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ahmed A AhmedThe School of Pharmacy, University College London, London WC1N 1AX, UK.ORCID 0000-0002-0409-7589
William GreenhalfDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 7BE, UK.
Daniel H PalmerDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 7BE, UK.
Nicole WilliamsAXIS Bioservices, Coleraine BT51 3RP, Northern Ireland, UK.
Jenny WorthingtonAXIS Bioservices, Coleraine BT51 3RP, Northern Ireland, UK.
Tariq ArshadQualigen Therapeutics, Carlsbad, CA 92011, USA.
Shozeb HaiderThe School of Pharmacy, University College London, London WC1N 1AX, UK.
Effrosyni AlexandrouThe School of Pharmacy, University College London, London WC1N 1AX, UK.
Dilek GuneriThe School of Pharmacy, University College London, London WC1N 1AX, UK.
Zoe A E WallerThe School of Pharmacy, University College London, London WC1N 1AX, UK.
Stephen NeidleThe School of Pharmacy, University College London, London WC1N 1AX, UK.ORCID 0000-0003-0622-6548
University College London · GBUniversity of Liverpool · GBGuy's Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council BB/W001616/1Cnacre Research UK C18616/A25153
6 · The paper itself

Abstract

The naphthalene diimide compound QN-302, designed to bind to G-quadruplex DNA sequences within the promoter regions of cancer-related genes, has high anti-proliferative activity in pancreatic cancer cell lines and anti-tumor activity in several experimental models for the disease. We show here that QN-302 also causes downregulation of the expression of the

Indexed as

G-QuadruplexesPancreatic NeoplasmsCalcium-Binding ProteinsCell Line, TumorGene ExpressionHumansNeoplasm ProteinsCalcium-Binding ProteinsNeoplasm ProteinsS100P protein, humanbiophysicsMIA PaCa-2 xenograftmolecular modelingpancreatic cancerquadruplexS100Ptranscriptome

Identifiers

PMID36985425
PMCPMC10051992
OpenAlexW4323566619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.